"Isn't there already an Alzheimer's /dementia trial planned and approved by the FDA? Come to think of it there is a kidney trial planned and approved as well."

I'm assuming that you are referring to new, unique trials and not the cognition or CKD sub-studies of BETonMACE. Other than BETonMACE, there are only 3 apabetalone trials listed on ClinicalTrials.gov that are not completed or terminated. These 3 are listed below. All 3 are in the "not yet recruiting" stage.

Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study

A Two-Part Phase 2a Study of RVX000222 in Patients With End-Stage Renal Disease Treated With Hemodialysis

Safety and Effect of Oral RVX000222 in Subjects With Fabry Disease

There is no Alzheimer's/Dementia trial listed on ClinicalTrials.gov. The renal trial listed above is for end stage renal disease in patients receiving hemodialysis ~3 times per week. This is a much for severe state of kidney disease than those patients in the BETonMACE CKD sub-study with eGFR>30 and not needing dialysis. To my knowledge, there has been no FDA approval of a Alzheimer's/Dementia or non-ESRD/dialysis CKD trial. These trials may have been proposed and/or planned by Resverlogix, but have yet to be FDA approved. Usually, listing of the upcoming trial on ClinicalTrials.gov is the first step.

BearDownAZ